Pharma Firms Seek 50% Price Hike in Key Cancer Drugs Including Carboplatin, Cisplatin, Approach NPPA: Report
New Delhi: Domestic drug manufacturers have sought a 50% increase in prices of key cancer medicines such as carboplatin, cisplatin and oxaliplatin, citing a sharp surge in platinum prices that…